[1]王蓓蓓,白 梅.黄芪建中汤加减联合四联疗法对Hp阳性胃溃疡患者Hp清除率及复发率的影响[J].医学信息,2022,35(20):145-147.[doi:10.3969/j.issn.1006-1959.2022.20.040]
　WANG Bei-bei,BAI Mei.Effect of Huangqi Jianzhong Decoction Combined with Quadruple Therapy on Hp Clearance Rate and Recurrence Rate in Patients with Hp Positive Gastric Ulcer[J].Journal of Medical Information,2022,35(20):145-147.[doi:10.3969/j.issn.1006-1959.2022.20.040]
点击复制

黄芪建中汤加减联合四联疗法对Hp阳性胃溃疡患者Hp清除率及复发率的影响()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年20期
页码:
145-147
栏目:
中医中药
出版日期:
2022-10-15

文章信息/Info

Title:
Effect of Huangqi Jianzhong Decoction Combined with Quadruple Therapy on Hp Clearance Rate and Recurrence Rate in Patients with Hp Positive Gastric Ulcer
文章编号:
1006-1959（2022）20-0145-03
作者:
王蓓蓓; 白 梅
（1.天津市黄河医院呼吸消化科，天津 300110；2.邹城市人民医院消化科，山东 邹城 273500）
Author(s):
WANG Bei-bei; BAI Mei
(1.Department of Respiratory and Digestive,Tianjin Huanghe Hospital,Tianjin 300110,China;2.Department of Gastroenterology,Zoucheng People’s Hospital,Zoucheng 273500,Shandong,China)
关键词:
幽门螺杆菌; 胃溃疡; 黄芪建中汤; 四联疗法
Keywords:
Helicobacter pylori; Gastric ulcer; Huangqi Jianzhong decoction; Quadruple therapy
分类号:
R573.1
DOI:
10.3969/j.issn.1006-1959.2022.20.040
文献标志码:
A
摘要:
目的 探究黄芪建中汤加减方联合四联疗法对幽门螺杆菌（Hp）阳性胃溃疡患者的Hp清除率及复发率的影响。方法 选取我院2019年9月-2021年5月收治的感染Hp胃溃疡患者260例，随机分为对照组与联合治疗组，各130例。对照组予以四联疗法治疗，联合治疗组予以黄芪建中汤加减方联合四联疗法治疗。比较两组药物治疗的临床疗效、Hp清除率和随访停药3个月后的复发率，并观察治疗期间药物不良反应发生情况。结果 联合治疗组临床疗效优于对照组（P＜0.05）；联合治疗组胃脘痛、反酸嗳气、纳差、口苦、口臭、大便干燥评分均低于对照组（P＜0.05）；联合治疗组Hp清除率为93.08%，高于对照组的58.46%（P＜0.05）；停药3个月后，联合治疗组Hp复发率为2.31%，低于对照组的15.38%（P＜0.05）。结论 黄芪建中汤加减联合四联疗法对感染Hp胃溃疡患者具有良好的临床疗效，对Hp具有高清除率、低复发率的作用，能有效改善患者预后，预防复发。
Abstract:
Objective To explore the effect of Huangqi Jianzhong decoction combined with quadruple therapy on helicobacter pylori(Hp) clearance rate and recurrence rate in patients with Hp positive gastric ulcer.Methods A total of 260 patients with Hp gastric ulcer admitted to our hospital from September 2019 to May 2021 were randomly divided into control group and combined treatment group, with 130 cases in each group. The control group was treated with quadruple therapy, and the combined treatment group was treated with Huangqi Jianzhong decoction combined with quadruple therapy. The clinical efficacy, Hp clearance rate and recurrence rate after 3 months of drug withdrawal were compared between the two groups, and the adverse drug reactions during treatment were observed.Results The clinical efficacy of the combined treatment group was better than that of the control group (P<0.05). The scores of epigastric pain, acid regurgitation, belching, anorexia, bitter taste, halitosis and dry stool in the combined treatment group were lower than those in the control group (P<0.05).The eradication rate of Hp in the combined treatment group was 93.08%, which was higher than 58.46% in the control group (P<0.05). After 3 months of withdrawal, the recurrence rate of Hp in the combined treatment group was 2.31%, which was lower than 15.38% in the control group（P<0.05）.Conclusion Huangqi Jianzhong decoction combined with quadruple therapy has a good clinical effect on patients with Hp gastric ulcer. It has a high clearance rate and low recurrence rate for Hpi, which can effectively improve the prognosis of patients and prevent recurrence.

参考文献/References:

[1]De Brito BB,da Silva FAF,Soares AS.Pathogenesis and clinical management of Helicobacter pylori gastric infection[J].World J Gastroenterol,2019,25(37):5578-5589.[2]Fischbach W,Malfertheiner P.Helicobacter Pylori Infection[J].Dtsch Arztebl Int,2018,115(25):429-436.[3]Narayanan M,Reddy KM,Marsicano E.Peptic Ulcer Disease and Helicobacter pylori infection[J].Mo Med,2018,115(3):219-224.[4]周钢.四联疗法根除幽门螺杆菌感染后复发情况及原因分析[J].中国药业,2020,29(12):90-92.[5]李若朴,王会颖.不同周期四联疗法根除幽门螺杆菌临床疗效及分析[J].中国临床医生杂志,2020,48(12):1438-1441.[6]Yang J,Zhang Y,Fan L.Eradication Efficacy of Modified Dual Therapy Compared with Bismuth-Containing Quadruple Therapy as a First-Line Treatment of Helicobacter pylori[J].Am J Gastroenterol,2019,114(3):437-445.[7]季锐,李延青.消化性溃疡病诊断与治疗规范建议(解读)[J].临床内科杂志,2014,31(8):575-576.[8]梁心慧,张钊,黄盎森.黄芪建中汤加减治疗脾胃气虚证功能性消化不良临床研究[J].世界中医药,2016,11(10):2026-2029.[9]万亚存,杨金枝,赵林灿.五味消毒饮与黄芪建中汤配合西药治疗幽门螺杆菌感染导致胃溃疡患者的安全性及有效性[J].中华医院感染学杂志,2016,26(19):4376-4378.[10]Dore MP,Bibbò S,Loria M.Twice-a-day PPI, tetracycline, metronidazole quadruple therapy with Pylera Lactobacillus reuteri for treatment na?觙ve or for retreatment of Helicobacter pylori. Two randomized pilot studies[J].Helicobacter,2019,24(6):e12659.[11]张志华,巩晓欢,马进福.双歧杆菌联合幽门螺杆菌根除四联疗法治疗青少年人群幽门螺旋杆菌感染的临床研究[J].实用临床医药杂志,2018,22(3):48-50.[12]杜志娜,尉迟敏,曲韬.泮托拉唑四联疗法加用胃黏膜保护剂对幽门螺杆菌阳性胃溃疡患者愈合质量的影响[J].实用医院临床杂志,2017,14(3):112-114.[13]张阳.加味黄芪建中汤联合西药治疗慢性胃炎脾胃虚寒证的疗效分析[J].检验医学与临床,2017,14(10):1479-1481.[14]江锋,刘慧敏,薛婧.中医药治疗幽门螺杆菌感染的现状分析与思考[J].中医杂志,2021,62(7):577-580,598.[15]王立颖,陈超,徐俊林.穴位敷贴联合黄芪建中汤在脾胃虚寒型慢性浅表性胃炎中的应用[J].中国中西医结合消化杂志,2017,25(4):310-311.[16]毕卫珍,戴苏宁,张涛.加味温胃汤联合三联疗法治疗Hp感染致胃脘痛的疗效及对胃液成分Hp根除率的影响[J].四川中医,2017,35(3):72-74.[17]秦华佗,杨英,刘雅雯.黄芪建中汤合枳实消痞丸加减治疗脾胃虚弱型功能性消化不良的疗效观察[J].中医药导报,2017,23(9):93-95.[18]魏桂双.中药黄芪建中汤与常规西医治疗胃溃疡临床疗效比较[J].现代中西医结合杂志,2014.23(14):1524-1525.[19]王建,马继征.连朴饮加减联合三联疗法治疗脾胃湿热型Hp感染阳性慢性胃炎70例临床研究[J].江苏中医药,2018,18(1):38-40.[20]N?觟st X,Pferschy-Wenzig EM,Nikles S.Identification of Constituents Affecting the Secretion of Pro-Inflammatory Cytokines in LPS-Induced U937 Cells by UHPLC-HRMS-Based Metabolic Profiling of the Traditional Chinese Medicine Formulation Huangqi Jianzhong Tang[J].Molecules,2019,24(17):3116.

相似文献/References:

[1]郭绍敏.克拉霉素四联方案对一线方案根除失败的幽门螺杆菌的再根除效果评估[J].医学信息,2018,31(02):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
　GUO Shao-min.Evaluation of the Re-eradication Effect of Clarithromycin Quadruple Regimen on Helicobacter Pylori Eradication Failure in the First Line Scheme[J].Journal of Medical Information,2018,31(20):121.[doi:10.3969/j.issn.1006-1959.2018.02.044]
[2]罗宜辉,刘代华.益生菌联合四联方案根除幽门螺杆菌的临床研究[J].医学信息,2018,31(11):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
　LUO Yi-hui,LIU Dai-hua.Clinical Study on the Eradication of Helicobacter Pylori by Probiotics Combined with Quadruple Regimen[J].Journal of Medical Information,2018,31(20):25.[doi:10.3969/j.issn.1006-1959.2018.11.008]
[3]薛守宇,廉 婷,耿爱民.补中益气活血方对胃溃疡患者血清TFF2和SOD水平的影响[J].医学信息,2022,35(10):105.[doi:10.3969/j.issn.1006-1959.2022.10.025]
　XUE Shou-yu,LIAN Ting,GENG Ai-min.Effect of Buzhong Yiqi Huoxue Recipe on Serum Levels of TFF2 and SOD in Patients with Gastric Ulcer[J].Journal of Medical Information,2022,35(20):105.[doi:10.3969/j.issn.1006-1959.2022.10.025]
[4]潮子健,汪文生,谢宏伟.年龄对胃部常见良性疾病患者的胃蛋白酶原及胃泌素-17水平的影响[J].医学信息,2018,31(23):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
　CHAO Zi-jian,WANG Wen-sheng,XIE Hong-wei.Effect of Age on Pepsinogen and Gastrin-17 Levels in Patients with Common Benign Diseases of the Stomach[J].Journal of Medical Information,2018,31(20):105.[doi:10.3969/j.issn.1006-1959.2018.23.028]
[5]朱爱娥,王菊艳.系统护理干预对慢性胃炎及胃溃疡患者临床疗效及生活质量的影响研究[J].医学信息,2019,32(04):188.[doi:10.3969/j.issn.1006-1959.2019.04.063]
　ZHU Ai-e,WANG Ju-yan.Effect of Systematic Nursing Intervention on Clinical Efficacy and Quality of Life in Patients with Chronic Gastritis and Stomach Ulcer[J].Journal of Medical Information,2019,32(20):188.[doi:10.3969/j.issn.1006-1959.2019.04.063]
[6]马艳会,寇 毅.幽门螺杆菌感染与结直肠腺瘤临床特征的相关性研究[J].医学信息,2022,35(16):102.[doi:10.3969/j.issn.1006-1959.2022.16.024]
　MA Yan-hui,KOU Yi.Correlation Between Helicobacter Pylori Infection and Clinical Features of Colorectal Adenoma[J].Journal of Medical Information,2022,35(20):102.[doi:10.3969/j.issn.1006-1959.2022.16.024]
[7]华启洋,吴同利,刘永艳,等.幽门螺杆菌在胃食管反流病发病中的作用[J].医学信息,2019,32(20):103.[doi:10.3969/j.issn.1006-1959.2019.20.029]
　HUA Qi-yang,WU Tong-li,LIU Yong-yan,et al.The Role of Helicobacter Pylori in the Pathogenesis of Gastroesophageal Reflux Disease[J].Journal of Medical Information,2019,32(20):103.[doi:10.3969/j.issn.1006-1959.2019.20.029]
[8]王晓琼,曾凡玲.体检者胃溃疡检出率及其影响因素分析[J].医学信息,2019,32(23):132.[doi:10.3969/j.issn.1006-1959.2019.23.039]
　WANG Xiao-qiong,ZENG Fan-ling.Analysis of the Detection Rate of Gastric Ulcer and its Influencing Factors in Physical Examination Patients[J].Journal of Medical Information,2019,32(20):132.[doi:10.3969/j.issn.1006-1959.2019.23.039]
[9]魏 明.铝碳酸镁与艾司奥美拉唑联合治疗胃溃疡的疗效[J].医学信息,2021,34(21):109.[doi:10.3969/j.issn.1006-1959.2021.21.029]
　WEI Ming.Effect of Magnesium Aluminate Combined with Esomeprazole in the Treatment of Gastric Ulcer[J].Journal of Medical Information,2021,34(20):109.[doi:10.3969/j.issn.1006-1959.2021.21.029]
[10]陶源,徐俊林,张艳,等.上消化道黏膜病变病理诊断结果分析[J].医学信息,2020,33(02):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
　TAO Yuan,XU Jun-lin,ZHANG Yan,et al.Analysis of Pathological Diagnosis for Upper Gastrointestinal Mucosal Lesions[J].Journal of Medical Information,2020,33(20):125.[doi:10.3969/j.issn.1006-1959.2020.02.036]
[11]黄 飞.不同用药方案治疗幽门螺杆菌感染胃溃疡的效果比较[J].医学信息,2020,33(16):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
　HUANG Fei.Comparison of the Effects of Different Medication Regimens in the Treatment of Gastric Ulcer Infected by Helicobacter Pylori[J].Journal of Medical Information,2020,33(20):156.[doi:10.3969/j.issn.1006-1959.2020.16.050]
[12]张 静,张鸿博.中医药治疗幽门螺杆菌相关性胃溃疡研究[J].医学信息,2022,35(20):173.[doi:10.3969/j.issn.1006-1959.2022.20.048]
　ZHANG Jing,ZHANG Hong-bo.Study on Traditional Chinese Medicine Treatment of Helicobacter Pylori Associated Gastric Ulcer[J].Journal of Medical Information,2022,35(20):173.[doi:10.3969/j.issn.1006-1959.2022.20.048]
[13]郭秋明,黄二苟.替普瑞酮联合改良四联疗法治疗Hp阳性胃溃疡的效果及对患者心理状态的影响[J].医学信息,2023,36(20):153.[doi:10.3969/j.issn.1006-1959.2023.20.031]
　GUO Qiu-ming,HUANG Er-gou.Effect of Teprenone Combined with Modified Quadruple Therapy on Hp Positive Gastric Ulcer and its Effect on Psychological State[J].Journal of Medical Information,2023,36(20):153.[doi:10.3969/j.issn.1006-1959.2023.20.031]

更新日期/Last Update: 1900-01-01